https://investor.ironwoodpharma.com/press-releases/press-release-details/2016/Ironwood-Pharmaceuticals-Progresses-Vascular-and-Fibrotic-Disease-Platform-with-Positive-Top-Line-Phase-Ia-Data-on-Soluble-Guanylate-Cyclase-Stimulator-IW-1701/default.aspx